XML 19 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' (DEFICIT) EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2022   72,817,887        
Beginning balance at Dec. 31, 2022 $ 145,700 $ 7 $ 561,390 $ (7,246) $ (408,451)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (36,829)       (36,829)  
Issuance of common stock to directors (in shares)   6,713        
Vesting of restricted stock units (in shares)   111,296        
Vesting of restricted stock units (2,959)   (2,959)      
Exercise of stock options (in shares)   19,483        
Exercise of stock options 131   131      
Stock-based compensation expense 11,056   11,056      
Other comprehensive income (loss) (700)     (700)    
Ending balance (in shares) at Mar. 31, 2023   72,955,379        
Ending balance at Mar. 31, 2023 116,399 $ 7 569,618 (7,946) (445,280)  
Beginning balance (in shares) at Dec. 31, 2023   73,366,766        
Beginning balance at Dec. 31, 2023 52,341 $ 7 595,781 (23,555) (519,892) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (32,923)       (32,923)  
Issuance of common stock to directors (in shares)   4,974        
Vesting of restricted stock units (in shares)   141,563        
Vesting of restricted stock units (2,862)   (2,862)      
Exercise of stock options (in shares)   43,460        
Exercise of stock options 345   345      
Repurchase of common stock (in shares)   (1,320,531)        
Repurchase of common stock (50,019)         (50,019)
Stock-based compensation expense 10,606   10,606      
Other comprehensive income (loss) $ 12,847     12,847    
Ending balance (in shares) at Mar. 31, 2024 72,200,000 72,236,232        
Ending balance at Mar. 31, 2024 $ (9,665) $ 7 $ 603,870 $ (10,708) $ (552,815) $ (50,019)